JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2022, 77(1):43-48 | DOI: 10.55095/CSPediatrie2022/007

Secondary hemophagocytic lymphohistiocytosis in SARS-CoV-2 infectionCase Histories

Radka Závodná, Lucie ©rámková, Martina Suková, Jan Starý
Klinika dětské hematologie a onkologie 2. LF UK a FN Motol

Hemophagocytic lymphohistiocytosis (HLH) is heterogeneous disease characterized by uncotrolled proliferation of T lymphocytes and macrophages result of which is overproduction of cytokines and hemophagocytosis. Without adequate therapy this condition could be life-threatening. We present a case of infant with secondary hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.

Keywords: hemophagocytic lymphohistiocytosis, COVID-19, pancytopenia, hepatosplenomegaly

Published: January 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Závodná R, ©rámková L, Suková M, Starý J. Secondary hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection. Ces-slov Pediat. 2022;77(1):43-48. doi: 10.55095/CSPediatrie2022/007.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Suková M, Mejstříková E, Vodičková E, et al. Hemofagocytující lymfohistiocytóza. Vnitr Lek 2010; 56(2): 157-169. Go to PubMed...
    2. Lima R, Filho CC, Ferreira Filho CM, et al. Hemophagocytic syndrome and COVID-19. [online]. Dostupné na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347481.
    3. Paul La Rosée, AnnaCarin Horne, Melissa Hines, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019; 133(23): 2465-2477. Go to original source... Go to PubMed...
    4. Rosado FGN, Kim AS. Hemophagocytic Lymphohistiocytosis: An Update on Diagnosis and Pathogenesis. Am J Clin Pathol 2013; 139(6): 713-727. Go to original source... Go to PubMed...
    5. WHO Coronavirus (COVID-19) Dashboard, 2021. [online]. Dostupné na: https://covid19.who.int/.
    6. Opoka-Winiarska V, Grywalska E, Roliński J. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? [online]. Dostupné na: https://doi.org/10.1186/s12916-020-01682-y. Go to original source... Go to PubMed...
    7. David J, ©ibíková M, Jonáą J, et al. Závaľná komplikace COVID-19 u dětí: syndrom multisystémové zánětlivé odpovědi. Pediatr Praxi 2021; 22(1): 8-11. Go to original source...
    8. Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Clin Pathol 2021; 191(1): 4-17. Go to original source... Go to PubMed...
    9. Retamozo S, Brito-Zerón P, Sisó-Almirall A, et al. Haemophagocytic syndrome and COVID-19. Clin Rheumatol 2021; 40: 1233-1244. Go to original source... Go to PubMed...
    10. Janka GE, Lehmberg K. Hemophagocytic syndromes--an update. Blood Rev 2014; 28(4): 135-42. Go to original source... Go to PubMed...
    11. Máca J, Sklienka P, Reimer P, Holub M. Nová definice sepse (Sepsis-3): cíle, přednosti a kontroverze. [online]. Dostupné na: https://www.prolekare.cz/casopisy/epidemiologie/2018-1-12/nova-definice-sepse-sepsis-3-cile-prednosti-a-kontroverze-63471. (Accessed July 01, 2021).

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content